The dilemma of screening for antibodies against low-frequency human platelet antigens
- 1 March 2005
- journal article
- Published by Wiley in Transfusion
- Vol. 45 (3) , 288-289
- https://doi.org/10.1111/j.1537-2995.2005.04479.x
Abstract
No abstract availableThis publication has 7 references indexed in Scilit:
- Microarray‐based genotyping for blood groups: comparison of gene array and 5′‐nuclease assay techniques with human platelet antigen as a modelTransfusion, 2005
- Immunization against a low‐frequency human platelet alloantigen in fetal alloimmune thrombocytopenia is not a single event: characterization by the combined use of reference DNA and novel allele‐specific cell lines expressing recombinant antigensTransfusion, 2005
- Finishing the euchromatic sequence of the human genomeNature, 2004
- Nomenclature of human platelet antigensVox Sanguinis, 2003
- Altruistic punishment in humansNature, 2002
- The human platelet alloantigens, PlA1 and PlA2, are associated with a leucine33/proline33 amino acid polymorphism in membrane glycoprotein IIIa, and are distinguishable by DNA typing.Journal of Clinical Investigation, 1989
- Monoclonal antibody--specific immobilization of platelet antigens (MAIPA): a new tool for the identification of platelet-reactive antibodiesBlood, 1987